Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AngioDynamics, Inc.
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
September 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
July 16, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
July 08, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 01, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
March 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
February 15, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
January 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
January 05, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
December 21, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
December 07, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
October 04, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
September 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
August 15, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
August 03, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
July 31, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
July 24, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
July 12, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
June 20, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
June 08, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Present at the Needham Virtual Healthcare Conference
April 11, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
March 30, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
March 13, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
AngioDynamics to Participate in Three Investor Conferences in March
February 28, 2023
From
AngioDynamics, Inc.
Via
Business Wire
Tickers
ANGO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit